Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Synthetic Anti-infective Drugs >  Quinolones >  GATIFLOXACIN MESYLATE

GATIFLOXACIN MESYLATE

Basic information Safety Supplier Related

GATIFLOXACIN MESYLATE Basic information

Product Name:
GATIFLOXACIN MESYLATE
Synonyms:
  • AM 1155 mesylate
  • AM 1155 MESYLATE;BMS 206584-01 MESYLATE;PD 135432 MESYLATE
  • BMS 206584-01 mesylate
  • Gatifloxacin mesylate (AM 1155 mesylate
  • PD 135432 mesylate)
  • GATIFLOXACIN MESYLATE
  • 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-(3-Methyl-1-piperazinyl)-4-oxo-, MonoMethanesulfonate (9CI)
  • GATIFLOXACIN MESYLATE USP/EP/BP
CAS:
316819-28-0
MF:
C19H22FN3O4.CH4O3S
MW:
471.503
Mol File:
316819-28-0.mol
More
Less

GATIFLOXACIN MESYLATE Chemical Properties

storage temp. 
Store at -20°C
solubility 
Soluble in DMSO
form 
Powder
InChIKey
PMMNVFFMFJMFDB-UHFFFAOYSA-N
SMILES
S(=O)(=O)(O)C.C1(=C(N2CC(C)NCC2)C(OC)=C2N(C3CC3)C=C(C(=O)C2=C1)C(=O)O)F
More
Less

GATIFLOXACIN MESYLATE Usage And Synthesis

Uses

Gatifloxacin mesylate is a fourth generation fluoroquinolone antibiotic with broad-spectrum antibacterial activity. It is able to inhibit bacterial type II topoisomerase (IC50 = 13.8 μg/ml for S. aureus topoisomerase IV) and E. coli DNA rotamase (IC50 = 0.109 μg/ml). It can be used to treat bacterial conjunctivitis in vivo, and its injection can treat acute urinary tract infections with efficacy comparable to levofloxacin hydrochloride injection[1].

in vivo

Gatifloxacin mesylate (subcutaneous injection; 100 mg/kg; 3 times a day; 30 days) significantly decreases the number of lesions in mouse footpad with Nocardia brasiliensis[4].

Animal Model:Female BALB/c mice with Nocardia brasiliensis in the right hind footpad.
Dosage:100 mg/kg
Administration:Subcutaneous injection; 3 times a day; 30 days
Result:Reduced the production of lesions in mice.

IC 50

Quinolone; Topoisomerase II: 36.7 μM (IC50)

References

[1] L. DENG. Observation on the curative effect of gatifloxacin mesylate injection in the treatment of acute urinary tract infections[J]. International Medical and Health Herald, 2009. DOI:10.3760/CMA.J.ISSN.1007-1245.2009.05.025.

GATIFLOXACIN MESYLATESupplier

Jiangxi ravel Biotechnology Co.,Ltd Gold
Tel
400-880-2824 18107960669
Email
79046690@qq.com
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Wuhan Fortuna Chemical Co., Ltd
Tel
027-59207852 13308628970
Email
buy@fortunachem.com
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
sales@meilune.com
BioBioPha Co., Ltd.
Tel
0871-65217109 13211707573;
Email
y.liu@mail.biobiopha.com
More
Less

GATIFLOXACIN MESYLATE(316819-28-0)Related Product Information